Sage Therapeutic Com (SAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,790 | -18,280 | -12,563 | -8,044 | 0 |
| Depreciation Amortization | 11 | 40 | 34 | 23 | 0 |
| Accounts payable and accrued liabilities | -471 | N/A | -40 | 525 | N/A |
| Other Working Capital | -124 | 590 | 20 | 703 | 0 |
| Other Operating Activity | 758 | 140 | 72 | -513 | 0 |
| Operating Cash Flow | $-5,616 | $-17,510 | $-12,477 | $-7,306 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -3 | -3 | -3 | 0 |
| Investing Cash Flow | $-3 | $-3 | $-3 | $-3 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2 | N/A | 37 | 35 | N/A |
| Other Financing Activity | 52,976 | 22,780 | 22,485 | 4,995 | 0 |
| Financing Cash Flow | $52,978 | $22,780 | $22,522 | $5,030 | $0 |
| Beginning Cash Position | 8,066 | 2,800 | 2,802 | 2,802 | 0 |
| End Cash Position | 55,425 | 8,060 | 12,844 | 523 | 0 |
| Net Cash Flow | $47,359 | $5,260 | $10,042 | $-2,279 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,616 | -17,510 | -12,477 | -7,306 | 0 |
| Capital Expenditure | -3 | N/A | -3 | -3 | N/A |
| Free Cash Flow | -5,619 | -17,510 | -12,480 | -7,309 | 0 |